Jake P. Taylor-King

@wildtypehuman

Co-founder at Relation (@relationrx) - applying #singlecell (check @scTrends_update !) #genomics #crispr #machinelearning to #drugdiscovery and #healthcare.

UK, Japan, sometimes USA

wildtypehuman.substack.com/welcome

Joined October 2014

Pinned
Jake P. Taylor-King
@wildtypehuman
Aug 3
Updated my substack. Expecting to post more in the next few months. wildtypehuman.substack.com/welcome
Jake P. Taylor-King
@wildtypehuman
Aug 27
The good and bad of medical research as a STEM grad: 1. It’s huge so there’s loads of great problems to study, but 2. It’s easy to find a problem that draws on your previous training — superficially making it feel like you’re meaningfully contributing. You seldom are because
MTS
@MTSlive
Aug 26
Alex Rubinsteyn on the 10 years of personalized cancer vaccine trials that went nowhere: sequence the cancer, build the vaccine, give it to the patient, then they die of cancer and you start another one "I switched from CS to biomedical research when personalized cancer vaccines
00:00
Jake P. Taylor-King
@wildtypehuman
Aug 26
As someone who knew some of these now MPs from Oxford days… It really makes me worry for the UK.
James Heale
@JAHeale
Aug 26
A plugged in parliament source flags that the ‘Sexy MP’ website is back up and running… here is the current top 10 MPs on it: sexymp.uk
Jake P. Taylor-King
@wildtypehuman
Aug 25
The best American single, and even better slowed down.
Dolly Parton - Jolene (33rpm slowed down digital version)
From youtube.com
Jake P. Taylor-King
@wildtypehuman
Aug 17
Is the dark secret of US healthcare that doctors just make too much money? Or is it the PBMs? The insurers make a few percent, the providers are on the brink of bankruptcy, drug spend is ~15% of total healthcare spend. Where else is the money going?
ApoStructura
@ApoStructura
Aug 16
Once again, insurance companies have a 3% profit margin. They physically do not have the money to approve more claims. The only way for them to approve more claims would be to raise insurance premiums.